INS and Insulin resistance: The changes after EMPG treatment were associated with the improvement in EMPG’s insulin resistance, which improved whole-body insulin sensitivity, thus improving peripheral glucose metabolism, reducing blood glucose levels, and prompting the heart of HF rats to use ketone body as the metabolic substrate, thus reducing cardiac glucose metabolism and improving lipid metabolism in HF rats.